What is Agrivida?
Founded in 2004, Agrivida operates at the forefront of industrial biotechnology, specializing in the development and distribution of advanced enzymes designed to optimize animal nutrition. By integrating sophisticated molecular biology with practical agricultural applications, the company addresses critical challenges in feed efficiency and sustainable production. Agrivida occupies a unique market position, bridging the gap between laboratory-scale innovation and large-scale commercial deployment in the global food supply chain. Its focus on enhancing the nutritional profile of feed products has made it a key player in the evolving agtech landscape, attracting significant interest from venture capital firms focused on long-term sustainability and resource efficiency.
How much funding has Agrivida raised?
Agrivida has raised a total of $95.9M across 8 funding rounds:
Private Equity
$2M
Series C
$15.2M
Debt
$1.2M
Series D
$23M
Series D
$23M
Series E
$20.4M
Unspecified
$11M
Debt
$150K
Private Equity (2011): $2M, investors not publicly disclosed
Series C (2012): $15.2M led by Kleiner Perkins, Alexandria, Presidio Ventures, DAG Ventures, Bright Capital, and PrairieGold Venture Partners
Debt (2014): $1.2M, investors not publicly disclosed
Series D (2014): $23M featuring ARCH Venture Partners, Northgate Capital, Cultivian Sandbox, Kleiner Perkins, DAG Ventures, Bright Capital Partners, PrairieGold Venture Partners, and Middleland Capital
Series D (2015): $23M backed by Kleiner Perkins Caufield & Byers, DAG Ventures, ARCH Venture Partners, Northgate Capital, Bright Capital Partners, Middleland Capital, Gentry Venture Partners, Cultivian Sandbox Ventures, and Prairie Gold
Series E (2016): $20.4M with participation from Cultivian Sandbox, Kleiner Perkins, Middleland Capital, ARCH Venture Partners, Northgate Capital, and University of Texas Investment Management Co.
Unspecified (2019): $11M led by ARCH Venture Partners, Open Prairie Rural Opportunities Fund, Maschhoff’s Agricultural Holdings, Syngenta Ventures, Cultivian Sandbox, Batios Holdings Limited, and Middleland Capital
Debt (2020): $150K supported by PPP
Key Investors in Agrivida
Kleiner Perkins
Kleiner Perkins is a Menlo Park-based venture capital firm that raises dedicated funds and invests in early and growth-stage technology and life-science companies, backing founders across consumer, enterprise, healthcare, and climate/hard tech.
ARCH Venture Partners
ARCH Venture Partners is a leading early-stage venture capital firm that creates and invests in life sciences and advanced technology companies, often co-founding startups with scientists and entrepreneurs to commercialize innovations.
Cultivian Sandbox
Cultivian Sandbox Ventures is focused on investing in innovative food and agriculture technology companies that address the evolving challenges in the sector, aiming to enhance sustainable production and healthy consumption.
What's next for Agrivida?
The recent capital injection positions Agrivida to further scale its operational footprint and accelerate the commercialization of its enzyme pipeline. Given the company's history of securing major enterprise-level funding, the current strategic focus likely involves expanding market penetration and refining its manufacturing processes to meet the growing global demand for sustainable agricultural solutions. As the firm matures, it remains well-positioned to leverage its deep-rooted partnerships with institutional investors to navigate the complexities of the life sciences market and drive continued innovation in animal health and nutrition.
See full Agrivida company page
